Effects of Nintedanib on Circulating Biomarkers in Patients With Progressive Pulmonary Fibrosis: Subgroup Analyses of the INBUILD Trial

Autor: T.M. Maher, R.G. Jenkins, F. Bonella, S. Assassi, I. Noth, C. Diefenbach, C. Ittrich, K.B. Rohr, M. Kolb, null on behalf of the INBUILD trial investigators
Rok vydání: 2023
Zdroj: A23. LEVERAGING IMAGING AND BIOSAMPLES TO IMPROVE DIAGNOSIS AND RISK PREDICTION IN ILA AND ILD.
Databáze: OpenAIRE